Apimeds Pharmaceuticals US Inc banner
A

Apimeds Pharmaceuticals US Inc
AMEX:APUS

Watchlist Manager
Apimeds Pharmaceuticals US Inc
AMEX:APUS
Watchlist
Price: 1.75 USD -8.38%
Market Cap: $22m

Profitability Summary

Apimeds Pharmaceuticals US Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Apimeds Pharmaceuticals US Inc

Margins Comparison
Apimeds Pharmaceuticals US Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Apimeds Pharmaceuticals US Inc
AMEX:APUS
22m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
376.8B USD
Loading...
Loading...
US
Exact Sciences Corp
NASDAQ:EXAS
361.6B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
188.1B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169.2B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.6B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67.9B AUD
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Apimeds Pharmaceuticals US Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Apimeds Pharmaceuticals US Inc
AMEX:APUS
22m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
376.8B USD
Loading...
Loading...
Loading...
Loading...
US
Exact Sciences Corp
NASDAQ:EXAS
361.6B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
188.1B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169.2B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.6B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67.9B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Apimeds Pharmaceuticals US Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett